Automation Gathers Pace in the Western European Liquid Handling Market
The escalating need for high throughput data is accelerating the shift towards automation in the Western European liquid handling market. Government investments in the development of bioclusters, as well as R&D centres for various drug discovery applications, are opening up opportunities for liquid handling companies in the region.
New analysis from Frost & Sullivan, Western European Liquid Handling Market, finds that the market earned revenues of $525 million in 2014 and estimates this to reach $890.7 million in 2021. Manual liquid handing systems discussed in this study include pipettes and consumables such as pipette tips and liquid containers. Automated instruments include all electronic pipettes and automated bench-top instruments.
Since most life science applications require sterile methods of handling liquids, non-contact dispensing is becoming an essential part of research laboratories.
• Researchers are promoting automated technologies such as acoustics and gas drive to eliminate contamination.
• Researchers are also working on super paramagnetic beads and a spatial light modulator for processing a large array of droplets.
• The advent of high-density microplate formats such as 384 and 1536 wells has enabled the screening of more compounds without extra cost for reagents.
“Laboratories prefer automated liquid handling systems, which can significantly reduce working hours for personnel,” said Frost & Sullivan Healthcare Senior Research Analyst Srinivas Sashidhar. “However, market participants must overcome several shortfalls before large scale laboratory automation is possible.”
For instance, the lack of open standards in product development and data transfer affects the compatibility between different components. As integration complexity grows, software compatibility too becomes a challenge. Further, the high price of automation equipment, along with laboratory consolidation across Europe compels laboratories to rethink liquid handling equipment purchases.
“Manufacturers must build automated equipment and accessories that are flexible for use with different liquid handling systems,” suggested Sashidhar. “Collaboration with reagent manufacturers will help create a greater number of validated protocols and widen the scope for expansion in the Western European liquid handling market.”
Western European Liquid Handling Market is part of the Life Sciences Growth Partnership Service programme.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance